openPR Logo
Press release

Lung Cancer Therapeutics Market Size, Share, Key Players Overview and Geographical Outlook 2026

10-02-2019 10:57 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt Ltd

Lung Cancer Therapeutics Market Size, Share, Key Players

The targeted segment is forecast to emerge dominant among various therapies in The Global Lung Cancer Therapeutics Market, finds Fortune Business Insights in a new study. The study is titled “Lung Cancer Therapeutics Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2026.” According to the study, the global lung cancer therapeutics market will exhibit an exponential CAGR of 13.0% to reach a value of US$ 48,725.9 Mn by 2026 from US$ 18,327.6 Mn in 2018.

Lung cancer is considered one of the leading causes of death by cancer. Cancer can be a result of continuous exposure to asbestos, and unhealthy lifestyle that includes habits such as pipe smoking, cigarette smoking, cigar smoking. The rising incidence of lung cancer is subsequently fuelling demand for various therapies in the global lung cancer therapeutics market.

Browse Complete Report:
https://www.fortunebusinessinsights.com/industry-reports/lung-cancer-therapeutics-market-100473

Key companies covered in the Lung Cancer Therapeutics Market Research report include

• Astellas Pharma US
• Celgene
• Merck Sharp & Dohme GmbH
• Pfizer
• Eli Lilly and Company
• Bristol-Myers Squibb
• AstraZeneca
• Boehringer Ingelheim Pharmaceutical, Takeda
• Novartis
• Sanofi.

Targeted therapy is expected to emerge dominant among other therapies such as vaccine therapy, radiation therapy, chemotherapy, surgery, and immunotherapy. targeted therapy segment accounted for a share of 51.1% in the year 2018. This is because of the rise in focus towards the diagnosis of lung cancer and the positive outcome of targeted therapy that is increasing its demand in the global market.

However, the immunotherapy segment is anticipated to grow at the fastest CAGR during the forecast period. This is because of the rise in the number of product launches related to treating lung cancer. The availability of abundant resources is creating new opportunities for growth in the market during the coming years.

Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-therapeutics-market-100473

Increasing Investments in Research and Development Activities to Boost Market

Various factors are responsible for boosting the global lung cancer therapeutics market. One among them is the launch of cancer awareness programs by both government and non-government organizations around the world. Cancer awareness and various treatment measures are increasing the demand for cancer therapeutics, especially in developing nations. Besides this, increasing investment by market players in research and development activities to discover novel therapeutics is driving the global market.

On the flip side, most of the anticipated drugs for lung cancer are still in their early testing stage and might take some time before finally getting launched in the market. This gestation gap between clinical trial and final launch might create uncertainty among players, making them skeptical about further investments in lung cancer treatment researches. This may hamper the market growth during the forecast period.

Furthermore, Cure for a certain type of cancer is yet to be discovered. The cure is yet to be discovered as targeted therapies have no effect on such cancer types. This is more likely to create challenges for the global market for lung cancer therapeutics during the forecast period.

The Asia Pacific to Emerge as the Fastest Growing Region with Rising in Cancer Awareness Programs

North America is expected to dominate the global market for lung cancer therapeutics. In 2018 the region generated a revenue of US$ 8,093.2 Mn. Growth in this region is attributable to the rising prevalence and diagnostics of lung cancer and the increasing adoption of advanced lung cancer therapeutics. Besides this, increasing awareness about cancer is enabling the market in Asia Pacific exhibit a faster CAGR.

A few novel therapeutics are introduced in the market, impelling leading players to research on improved medication. For instance, Genentech, a company operating in the lung cancer therapeutics market has recently launched their new drug named, Alecensa (alectinib), in order to treat ALK-positive non-small cell lung cancer. Such strategies adopted by players will bode well for the global lung cancer therapeutics market in the long run.

Global Lung Cancer Therapeutics Market Segmentation
By Therapy
• Targeted Therapy
o Bevacizumab
o Dabrafenib/Trametinib
o Erlotinib Hydrochloride
o Osimertinib
o Others
• Immunotherapy
o Durvalumab
o Nivolumab
o Atezolizumab
o Pembrolizumab
• Chemotherapy

By Cancer Type
• Non-small cell lung cancer (NSCLC)
• Small cell lung cancer (SCLC)

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Get Discount:
https://www.fortunebusinessinsights.com/enquiry/check-discount/lung-cancer-therapeutics-market-100473

KEY QUESTIONS ANSWERED:

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Therapeutics Market Size, Share, Key Players Overview and Geographical Outlook 2026 here

News-ID: 1841892 • Views:

More Releases from Fortune Business Insights Pvt Ltd

Aircraft Engine Market Latest Key Drivers and Future Demand Forecast by 2029
Aircraft Engine Market Latest Key Drivers and Future Demand Forecast by 2029
According to a recent report by Fortune Business Insights, the global Aircraft Engine Market is expected to reach a size of USD 112.61 billion by 2028, growing at a CAGR of 10.87% during the forecast period 2021-2028. The report offers a thorough analysis of the market size, regional landscape, revenue forecasts, and upcoming challenges in the market. It also provides current statistics and future predictions, aiming to evaluate growth prospects,
Space Mining Market the Development Strategies Adopted by Major Key Players And …
The increasing investments by mining companies is expected to foster healthy growth of the market during the forecast period, sates Fortune Business Insights in a report, titled "Space Mining Market Size, Share & Industry Analysis, By Phase (Spacecraft Design, Launch, Operation), By Asteroid type (Type C, Type S, Type M, Others), By Application (Construction, Resource Harvesting, 3D Printing, Others) and Regional Forecast, 2023-2030." The growing number of government initiatives for
Radar Level Transmitter Market Size, Gross Margin, Trends, Future Demand, Analys …
The higher level of accuracy, reliability, and stability offered by radar level transmitters is expected to fuel the demand of the market during the forecast period, states Fortune Business Insights, in a report, titled "Radar Level Transmitter Market Size, Share & Industry Analysis, By Technology (Contact, Noncontact), By Frequency Range (C and X Band, W Band, K Band), By Application (Liquids, slurries, and interfaces, Solids), By Industry (Oil & Gas,
Explosive Detectors Market Analysis, Growth, Trends, Demands and Emerging Techno …
The global explosive detectors market is set to gain traction from their ever-increasing usage in the security check-in department of domestic, as well as international airports worldwide. This information is published by Fortune Business Insights™ in an upcoming report, titled, "Explosive Detectors Market Size, Share & Industry Analysis, By Technology (Trace Detector, Bulk Detector), By Product Type (Vehicle Mounted, Handheld, Robotics, Others), By End User (Military & Defense, Cargo &

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top